34 related articles for article (PubMed ID: 31643060)
1. Intact quantitation of cysteine-conjugated antibody-drug conjugates using native mass spectrometry.
Li Y; Wang Y; Shenoy VM; Niu S; Jenkins GJ; Sarvaiya H
Rapid Commun Mass Spectrom; 2024 Aug; 38(15):e9774. PubMed ID: 38812280
[TBL] [Abstract][Full Text] [Related]
2. A simple and highly sensitive LC-MS workflow for characterization and quantification of ADC cleavable payloads.
Mak SY; Chen S; Fong WJ; Choo A; Ho YS
Sci Rep; 2024 May; 14(1):11018. PubMed ID: 38744902
[TBL] [Abstract][Full Text] [Related]
3. Improved characterization of trastuzumab deruxtecan with PTCR and internal fragments implemented in middle-down MS workflows.
Beaumal C; Deslignière E; Diemer H; Carapito C; Cianférani S; Hernandez-Alba O
Anal Bioanal Chem; 2024 Jan; 416(2):519-532. PubMed ID: 38008785
[TBL] [Abstract][Full Text] [Related]
4. A single backbone amide modification method to achieve single site-specific chemical protein conjugation.
Guo M; Lei Y; Zhao K; Guo L; Dang B
Methods Enzymol; 2024; 698():57-88. PubMed ID: 38886040
[TBL] [Abstract][Full Text] [Related]
5. Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future.
Beck A; D'Atri V; Ehkirch A; Fekete S; Hernandez-Alba O; Gahoual R; Leize-Wagner E; François Y; Guillarme D; Cianférani S
Expert Rev Proteomics; 2019 Apr; 16(4):337-362. PubMed ID: 30706723
[TBL] [Abstract][Full Text] [Related]
6. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
[TBL] [Abstract][Full Text] [Related]
7. Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis.
Janin-Bussat MC; Dillenbourg M; Corvaia N; Beck A; Klinguer-Hamour C
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb; 981-982():9-13. PubMed ID: 25596378
[TBL] [Abstract][Full Text] [Related]
8. Drug deconjugation-assisted peptide mapping by LC-MS/MS to identify conjugation sites and quantify site occupancy for antibody-drug conjugates.
Wang T; Huang ZA; Zhou M; Wang R; Li Y; Guo L; Cao X; Huang J
J Pharm Biomed Anal; 2024 Jun; 243():116098. PubMed ID: 38493753
[TBL] [Abstract][Full Text] [Related]
9. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
[TBL] [Abstract][Full Text] [Related]
10. Conjugation Site Analysis by MS/MS Protein Sequencing.
Han L; Zhao Y; Zhang Q
Methods Mol Biol; 2020; 2078():221-233. PubMed ID: 31643060
[TBL] [Abstract][Full Text] [Related]
11. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
Friese OV; Smith JN; Brown PW; Rouse JC
MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
